γ-H2AX foci in peripheral blood lymphocytes to quantify radiation-induced DNA damage after 177Lu-DOTA-octreotate peptide receptor radionuclide therapy.
Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands jan.bussink@radboudumc.nl.
Johan
J
Bussink
Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Paul N
PN
Span
D004249:DNA Damage; D005260:Female; D006657:Histones / Q000737:chemistry*; D006801:Humans; D008214:Lymphocytes / Q000528:radiation effects*; D008297:Male; D018358:Neuroendocrine Tumors / Q000628:therapy*; D015282:Octreotide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use*
C554548:177Lu-octreotate; C468783:H2AX protein, human; D006657:Histones; D009942:Organometallic Compounds; C447941:lutetium Lu 177 dotatate; D015282:Octreotide